STT
64
4
AXP
69
3
HAL
60
2
FMC
33
2
SYK
68
4
XYL
45
8
DVN
18
2
ROP
59
5
FDX
40
4
CB
51
3
ADP
66
2
ILMN
37
5
URBN
42
4
VRSN
57
4
BA
49
-3
PH
73
3
AEP
53
2
WDC
43
2
ROST
52
5
AEE
64
4
STT
64
4
AXP
69
3
HAL
60
2
FMC
33
2
SYK
68
4
XYL
45
8
DVN
18
2
ROP
59
5
FDX
40
4
CB
51
3
ADP
66
2
ILMN
37
5
URBN
42
4
VRSN
57
4
BA
49
-3
PH
73
3
AEP
53
2
WDC
43
2
ROST
52
5
AEE
64
4
Financhill
Back

Bio-Path Holdings Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
13

BPTH
Bio-Path Holdings

Last Price:
0.79
Seasonality Move:
-1.41%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Bio-Path Holdings Price Quote

$0.79
-0.01 (-1.13%)
(Updated: November 22, 2024 at 5:55 PM ET)

Bio-Path Holdings Key Stats

Sell
13
Bio-Path Holdings (BPTH) is a Sell
Day range:
$0.74 - $0.85
52-week range:
$0.61 - $12.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
46.6K
Avg. volume:
133.8K
1-year change:
-92.01%
Market cap:
$3.4M
Revenue:
$0
EPS:
$-11.03

How Much Does Bio-Path Holdings Make?

Data Unavailable

Is Bio-Path Holdings Growing As A Company?

Data Unavailable

Bio-Path Holdings Stock Price Performance

  • Did Bio-Path Holdings Stock Go Up Last Month?
    Bio-Path Holdings share price went down by -25.33% last month
  • Did BPTH's Share Price Rise Over The Last Year?
    BPTH share price fell by -92.01% over the past 1 year

What Is Bio-Path Holdings 52-Week High & Low?

Bio-Path Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bio-Path Holdings?

  • How Much Debt Does Bio-Path Holdings Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Bio-Path Holdings Have?
    Cash and short term investments quarterly total is $562K
  • What Is Bio-Path Holdings’s Book Value Per Share?
    Book value per share is -0.19

Is Bio-Path Holdings Cash Flow Positive?

  • What Is BPTH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$9.5M
  • What Is Bio-Path Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $7.7M
  • What Is Bio-Path Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Bio-Path Holdings Return On Invested Capital

Data Unavailable

Bio-Path Holdings Earnings Date & Stock Price

Bio-Path Holdings Competitors

  • Who Are Bio-Path Holdings's Competitors?
    Below is a list of companies who compete with Bio-Path Holdings or are related in some way:
    • Aadi Bioscience Inc (AADI)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Bio-Path Holdings Dividend Yield

Bio-Path Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 31.37%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 12.00
Upside from Last Price: 1401.88%

Major Shareholders

  • How many BPTH shares are owned by institutional investors?
    126.5K BPTH shares are owned by institutional investors
  • How many BPTH shares are owned by insiders?
    0 BPTH shares are owned by insiders